Pacific Biosciences of California, Inc. (PACB) revenue

Revenue · fiscal 2025
$160.01M

Pacific Biosciences of California, Inc. (PACB) reported revenue of $160.01M in fiscal 2025 (the year ended December 31, 2025). That is 3.9% higher than the $154.01M of fiscal 2024. Figures as of 18 Nov 2026, 09:32 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$160.01M
Change on fiscal 2024
+3.9%
Growth, 5 years
+15.2% a year
Growth, 10 years
+5.6% a year
Highest on record
$200.52Mfiscal 2023
Lowest on record
$135.00Kfiscal 2009
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Pacific Biosciences of California, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 15.2% a year; over ten years the rate was 5.6% a year. Across the 17 fiscal years on record (2009–2025), the highest was $200.52M in fiscal 2023 and the lowest $135.00K in fiscal 2009.

History · 17 fiscal years

Revenue by fiscal year

Pacific Biosciences of California, Inc. revenue, year by year

Pacific Biosciences of California, Inc. (PACB) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$160.01M 3.9% up
2024$154.01M 23.2% down
2023$200.52M 56.3% up
2022$128.30M 1.7% down
2021$130.51M 65.4% up
2020$78.89M 13.2% down
2019$90.89M 15.6% up
2018$78.63M 15.9% down
2017$93.47M 3.0% up
2016$90.71M 2.2% down
2015$92.78M 53.1% up
2014$60.59M 115.0% up
2013$28.18M 8.5% up
2012$25.98M 23.3% down
2011$33.86M 1,922.9% up
2010$1.67M 1,140.0% up
2009$135.00K—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on PACB

Pacific Biosciences of California, Inc., figure by figure

Pacific Biosciences of California, Inc. (PACB) overview: price, valuation and scorecard

Pacific Biosciences of California, Inc. revenue: questions and answers

What is Pacific Biosciences of California, Inc.'s revenue?

Pacific Biosciences of California, Inc. (PACB) reported revenue of $160.01M in fiscal 2025 (the year ended December 31, 2025). That is 3.9% higher than the $154.01M of fiscal 2024.

What is the growth rate of Pacific Biosciences of California, Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 15.2% a year; over ten years the rate was 5.6% a year.

What are the highest and lowest revenue figures on record for Pacific Biosciences of California, Inc.?

Across the 17 fiscal years on record (2009–2025), the highest was $200.52M in fiscal 2023 and the lowest $135.00K in fiscal 2009.

How is Pacific Biosciences of California, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Pacific Biosciences of California, Inc. it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Pacific Biosciences of California, Inc. (PACB) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/PACB/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.